Clearance Summary
AGILIA INFUSION SYSTEM received FDA 510(k) clearance under submission number K121613, sponsored by Fresenius Kabi AG. The device was reviewed via the Traditional premarket notification pathway and assigned to the General Hospital review panel. The statutory decision date of record is 2013-05-01.
- Submission: K121613
- Applicant / Sponsor: Fresenius Kabi AG
- Clearance pathway: Traditional
- Review panel: General Hospital
- Device class: Class II
- Regulation citation: 21 CFR 880.5725
- Decision date: 2013-05-01
Classification & Regulation
This clearance is catalogued under FDA product code FRN and 21 CFR 880.5725, within the General Hospital review panel as a Class II device.